Search

Your search keyword '"Fairley Christopher K"' showing total 38 results
Start Over Author "Fairley Christopher K" Journal medical journal of australia
38 results on '"Fairley Christopher K"'

1. Infectious syphilis in women and heterosexual men in major Australian cities: sentinel surveillance data, 2011–2019

Author

Carter, Allison, primary, McManus, Hamish, additional, Ward, James S, additional, Vickers, Tobias, additional, Asselin, Jason, additional, Baillie, Greta, additional, Chow, Eric PF, additional, Chen, Marcus Y, additional, Fairley, Christopher K, additional, Bourne, Christopher, additional, McNulty, Anna, additional, Read, Phillip, additional, Heath, Kevin, additional, Ryder, Nathan, additional, McCloskey, Jenny, additional, Carmody, Christopher, additional, McCormack, Heather, additional, Alexander, Kate, additional, Casey, Dawn, additional, Stoove, Mark, additional, Hellard, Margaret E, additional, Donovan, Basil, additional, and Guy, Rebecca J, additional

Published
2023
Full Text
View/download PDF

3. The acceptability and usability of two HIV self‐test kits among men who have sex with men: a randomised crossover trial

Author

Lee, Dana YL, primary, Ong, Jason J, additional, Smith, Kirsty, additional, Jamil, Muhammad S, additional, McIver, Ruthy, additional, Wigan, Rebecca, additional, Maddaford, Kate, additional, McNulty, Anna, additional, Kaldor, John M, additional, Fairley, Christopher K, additional, Bavinton, Benjamin, additional, Chen, Marcus, additional, Chow, Eric PF, additional, Grulich, Andrew E, additional, Holt, Martin, additional, Conway, Damian P, additional, Stoove, Mark, additional, Wand, Handan, additional, and Guy, Rebecca J, additional

Published
2022
Full Text
View/download PDF

4. The acceptability and usability of two HIVself‐test kits among men who have sex with men: a randomised crossover trial

Author

Lee, Dana YL, Ong, Jason J, Smith, Kirsty, Jamil, Muhammad S, McIver, Ruthy, Wigan, Rebecca, Maddaford, Kate, McNulty, Anna, Kaldor, John M, Fairley, Christopher K, Bavinton, Benjamin, Chen, Marcus, Chow, Eric PF, Grulich, Andrew E, Holt, Martin, Conway, Damian P, Stoove, Mark, Wand, Handan, and Guy, Rebecca J

Abstract

To compare the usability and acceptability of oral fluid‐ and blood‐based HIV self‐test kits among men who have sex with men in Australia. Randomised crossover trial. Gay, bisexual, and other men aged 18 years or older who have sex with men, who attended two metropolitan sexual health clinics in Sydney and Melbourne, 7 January – 10 December 2019. Ease of use of HIV self‐test kits; preferred HIV self‐test type; difficulties encountered during HIV self‐testing. 170 men were recruited (median age, 34 years; interquartile range, 29–43 years); 144 identified as gay (85%), 96 were born outside Australia (57%). Participants were more likely to report the oral fluid HIV self‐test was easy to use than the blood‐based self‐test (oral fluid, 99%; blood, 86%; odds ratio [OR], 3.0; 95% confidence interval [CI], 1.4–6.6). The oral fluid test was preferred by 98 participants (58%; 95% CI, 50–65%), the blood‐based test by 69 (41%; 95% CI, 33–48%). Difficulties with the oral fluid test kit identified by observing nurses included problems placing the buffer solution into the stand (40 of 170 participants, 24%) and not swabbing both gums (23 of 169, 14%); difficulties with the blood‐based test kit included problems filling the device test channel (69 of 170, 41%) and squeezing the finger firmly enough to generate a blood drop (42 of 170, 25%). No participant received an invalid result with the oral fluid self‐test; two of 162 participants (1%) received invalid results with the blood self‐test. After adjusting for age, education level, and ethnic background, characteristics associated with higher odds of using HIV self‐testing in the future were overseas birth (adjusted OR, 3.07; 95% CI, 1.42–6.64), and self‐evaluated ease of use and confidence in using the kits. It is important to provide options for obtaining both oral fluid‐ and blood‐based HIV self‐tests. The usability and acceptability of both kits were high, but the ease of use and perceived accuracy influenced test kit preference.

Published
2022
Full Text
View/download PDF

5. Sexually transmissible infections among transgender men and women attending Australian sexual health clinics

Author

Callander, Denton, primary, Cook, Teddy, additional, Read, Phillip, additional, Hellard, Margaret E, additional, Fairley, Christopher K, additional, Kaldor, John M, additional, Vlahakis, Emanuel, additional, Pollack, Alisa, additional, Bourne, Christopher, additional, Russell, Darren B, additional, Guy, Rebecca J, additional, and Donovan, Basil, additional

Published
2019
Full Text
View/download PDF

6. Early initiation of antiretroviral therapy for people newly diagnosed with HIV infection in Australia: trends and predictors, 2004–2015

Author

McManus, Hamish, primary, Callander, Denton, additional, Donovan, Basil, additional, Russell, Darren B, additional, O'Connor, Catherine C, additional, Davies, Stephen C, additional, Lewis, David A, additional, Hellard, Margaret E, additional, Chen, Marcus Y, additional, Petoumenos, Kathy, additional, Varma, Rick, additional, Cogle, Aaron, additional, Boyd, Mark Alastair, additional, Grulich, Andrew, additional, Pollard, James, additional, Medland, Nick, additional, Fairley, Christopher K, additional, and Guy, Rebecca J, additional

Published
2019
Full Text
View/download PDF

7. Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data

Author

Ali, Hammad, primary, McManus, Hamish, additional, O'Connor, Catherine C, additional, Callander, Denton, additional, Kong, Marlene, additional, Graham, Simon, additional, Saulo, Dina, additional, Fairley, Christopher K, additional, Regan, David G, additional, Grulich, Andrew, additional, Low, Nicola, additional, Guy, Rebecca J, additional, and Donovan, Basil, additional

Published
2017
Full Text
View/download PDF

8. Neurosyphilis‐related hospital admissions, Australia, 2007–20.

Author

Aung, Ei T, Chen, Marcus Y, Fairley, Christopher K, Ong, Jason J, and Chow, Eric PF

Abstract

In Australia, information about neurosyphilis epidemiology is limited because national surveillance reports do not usually stratify data by syphilis stage.[1] However, neurosyphilis-related hospital admission rates can serve as proxy measures of its prevalence. Improving the collection of neurosyphilis surveillance data and integrating neurosyphilis incidence data into syphilis reports may enhance our understanding of the epidemiology of neurosyphilis. Keywords: Sexually transmitted diseases; Surveillance; Cost of illness EN Sexually transmitted diseases Surveillance Cost of illness 180 181 2 03/08/23 20230301 NES 230301 The annual number of infectious syphilis notifications in Australia increased four-fold during 2011-2019, from 1332 to 5912,[1] and similar rises for tertiary syphilis, including neurosyphilis, are anticipated. [Extracted from the article]

Published
2023
Full Text
View/download PDF

10. Early initiation of antiretroviral therapy for people newly diagnosed with HIVinfection in Australia: trends and predictors, 2004–2015

Author

McManus, Hamish, Callander, Denton, Donovan, Basil, Russell, Darren B, O'Connor, Catherine C, Davies, Stephen C, Lewis, David A, Hellard, Margaret E, Chen, Marcus Y, Petoumenos, Kathy, Varma, Rick, Cogle, Aaron, Boyd, Mark Alastair, Grulich, Andrew, Pollard, James, Medland, Nick, Fairley, Christopher K, and Guy, Rebecca J

Abstract

To determine trends in and predictors of early treatment for people newly diagnosed with human immunodeficiency virus (HIV) infection in Australia. Retrospective cohort analysis of routinely collected longitudinal data from 44 sexual health clinics participating in the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS) program. Patients diagnosed with HIVinfections, January 2004 – June 2015. Commencement of antiretroviral therapy within 6 months of HIVdiagnosis (early treatment); demographic, clinical, and risk group characteristics of patients associated with early treatment; trends in early treatment, by CD4+cell count at diagnosis. 917 people were diagnosed with HIVinfections, their median age was 34 years (interquartile range [IQR]: 27–43 years), and 841 (92%) were men; the median CD4+cell count at diagnosis was 510 cells/μL (IQR, 350–674 cells/μL). The proportion of patients who received early treatment increased from 17% (15 patients) in 2004–06 to 20% (34 patients) in 2007–09, 34% (95 patients) in 2010–12, and 53% (197 patients) in 2013–15 (trend, P< 0.001). The probability of early treatment, which increased with time, was higher for patients with lower CD4+cell counts and higher viral loads at diagnosis. The proportion of people newly diagnosed with HIVin sexual health clinics in Australia who received treatment within 6 months of diagnosis increased from 17% to 53% during 2004–2015, reflecting changes in the CD4+cell count threshold in treatment guidelines. Nevertheless, further strategies are needed to maximise the benefits of treatment to prevent viral transmission and morbidity.

Published
2019
Full Text
View/download PDF

12. High chlamydia positivity rates in Indigenous people attending Australian sexual health services

Author

O'Connor, Catherine C, primary, Ali, Hammad, additional, Guy, Rebecca J, additional, Templeton, David J, additional, Fairley, Christopher K, additional, Chen, Marcus Y, additional, Dickson, Bridget M, additional, Marshall, Lewis J, additional, Grulich, Andrew E, additional, Hellard, Margaret E, additional, Kaldor, John M, additional, Donovan, Basil, additional, and Ward, James S, additional

Published
2014
Full Text
View/download PDF

13. Chlamydia prevalence in young attenders of rural and regional primary care services in Australia: a cross‐sectional survey

Author

Yeung, Anna H, primary, Temple‐Smith, Meredith, additional, Fairley, Christopher K, additional, Vaisey, Alaina M, additional, Guy, Rebecca, additional, Law, Matthew G, additional, Low, Nicola, additional, Bingham, Amie L, additional, Gunn, Jane, additional, Kaldor, John, additional, Donovan, Basil, additional, and Hocking, Jane S, additional

Published
2014
Full Text
View/download PDF

14. Trends in chlamydia positivity among heterosexual patients from the Victorian Primary Care Network for Sentinel Surveillance, 2007–2011

Author

Lim, Megan S C, primary, El‐Hayek, Carol, additional, Goller, Jane L, additional, Fairley, Christopher K, additional, Nguyen, Phuong L T, additional, Hamilton, Rochelle A, additional, Henning, Dorothy J, additional, McNamee, Kathleen M, additional, Hellard, Margaret E, additional, and Stoove, Mark A, additional

Published
2014
Full Text
View/download PDF

29. Safe drinking water

Author

Padiglione, Alex A, primary, Hellard, Margaret E, additional, Sinclair, Martha I, additional, and Fairley, Christopher K, additional

Published
1997
Full Text
View/download PDF

34. Is HPV always sexually acquired?

Author

Fairley, Christopher K, primary, Tabrizi, Sepehr N, additional, McNeil, John J, additional, Chen, Shujun, additional, Borg, Anthony J, additional, and Garland, Suzanne M, additional

Published
1993
Full Text
View/download PDF

38. Infectious diseases. 6: Sexually transmitted infections: new diagnostic approaches and treatments.

Author

Bowden FJ, Tabrizi SN, Garland SM, and Fairley CK

Subjects
Adolescent, Anti-Bacterial Agents therapeutic use, Antiviral Agents therapeutic use, Contact Tracing, Female, Humans, Male, Sexually Transmitted Diseases diagnosis, Sexually Transmitted Diseases therapy
Abstract

1. Commercially available nucleic acid amplification assays (eg, polymerase or ligase chain reaction) are now the "gold standard" tests for genital chlamydial infection and also have a role in screening for gonococcal infection. 2. Single-dose oral antibiotics are available for treatment of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infections. 3. Strains of N. gonorrhoeae in urban Australia are often penicillin resistant, while strains from South East Asia and those in homosexually active men may show high-level resistance to quinolones. 4. Imiquimod, a novel immune-response modifier, is now available for effective, safe, self-administered treatment of genital warts. 5. The Pap smear remains the cornerstone of screening for precursor lesions of cervical cancer, but human papillomavirus genotyping may have a role in clinical decision-making for women with equivocal or early precancerous lesions. 6. Treatment of primary genital herpes changes the clinical course, and long-term suppressive therapy is effective for those with multiple recurrences. New technologies have made diagnosis and screening easier for patients and clinicians

Published
2002
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results